Pharmacogenomics in allogeneic hematopoietic stem cell transplantation: Implications on supportive therapies and conditioning regimens

被引：0
|
作者：
Morris, Sarah A. [1 ,2 ]
Nguyen, D. Grace [1 ,2 ]
Patel, Jai N. [1 ,2 ]
机构：
[1] Atrium Hlth, Dept Canc Pharmacol & Pharmacogen, 1021 Morehead Med Dr, Charlotte, NC 28204 USA
[2] Atrium Hlth, Levine Canc Inst, 1021 Morehead Med Dr, Charlotte, NC 28204 USA
来源：
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2023年 / 36卷 / 02期
关键词：
Pharmacogenomics; Pharmacogenetics; Supportive care; Bone marrow transplant; Hematopoietic stem cell transplantation; Allogeneic transplantation; VERSUS-HOST-DISEASE; CONSORTIUM CPIC GUIDELINES; DRUG-METABOLIZING-ENZYMES; CYCLOPHOSPHAMIDE PHARMACOKINETICS; CYP2C19; POLYMORPHISMS; GENE POLYMORPHISMS; PEDIATRIC-PATIENTS; VORICONAZOLE; ASSOCIATION; TACROLIMUS;
D O I：
10.1016/j.beha.2023.101470
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Allogeneic hematopoietic stem cell transplantation mortality has declined over the years, though prevention and management of treatment-related toxicities and post-transplant complications remains challenging. Applications of pharmacogenomic testing can potentially mitigate adverse drug outcomes due to interindividual variability in drug metabolism and response. This review summarizes clinical pharmacogenomic applications relevant to hematopoietic stem cell transplantation, including antifungals, immunosuppressants, and supportive care management, as well as emerging pharmacogenomic evidence with conditioning regimens.
引用
收藏
页数：11
相关论文
共 50 条
  • [21] Implications of ABO incompatibility in Allogeneic Hematopoietic Stem Cell Transplantation
    Raturi, Manish
    Das, Kunal
    Kala, Mansi
    Kusum, Anuradha
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 231 - 231
  • [22] The Gonadotoxic Effects of Conditioning Chemotherapy Regimens Prior to Hematopoietic Stem Cell Transplantation
    Jiang, Heng
    Dong, Rosemary
    Kim, So-Youn
    Luan, Yi
    Thonen, Macy
    Wadhwa, Aman
    OBSTETRICS AND GYNECOLOGY, 2023, 141 : 22S - 22S
  • [23] Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Aplastic Anemia: A Comparison of 3 Conditioning Regimens in 202 Consecutive Cases
    Ahmed, Parvez
    Chaudhry, Qamar Un Nisa
    Mahmood, Syed Karman
    Satti, Tariq Mahmood
    Khan, Mehreen Ali
    Shahbaz, Nighat
    Satti, Humayoon Shafique
    BLOOD, 2014, 124 (21)
  • [24] Comparison of Intravenous with Oral Busulfan in Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Regimens for Pediatric Acute Leukemia
    Kato, Motohiro
    Takahashi, Yoshiyuki
    Tomizawa, Daisuke
    Okamoto, Yasuhiro
    Inagaki, Jiro
    Koh, Katsuyoshi
    Ogawa, Atsushi
    Okada, Keiko
    Cho, Yuko
    Takita, Junko
    Goto, Hiroaki
    Sakamaki, Hisashi
    Yabe, Hiromasa
    Kawa, Keisei
    Suzuki, Ritsuro
    Kudo, Kazuko
    Kato, Koji
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (12) : 1690 - 1694
  • [25] Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation
    Fukuda, T
    Hackman, RC
    Guthrie, KA
    Sandmaier, BM
    Boeckh, M
    Maris, MB
    Maloney, DG
    Deeg, HJ
    Martin, PJ
    Storb, RF
    Madtes, DK
    BLOOD, 2003, 102 (08) : 2777 - 2785
  • [26] Comparison Of Intravenous With Oral Busulfan In Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimens For Pediatric Acute Leukemia
    Kato, Motohiro
    Takahashi, Yoshiyuki
    Tomizawa, Daisuke
    Okamoto, Yasuhiro
    Inagaki, Jiro
    Koh, Katsuyoshi
    Ogawa, Atsushi
    Okada, Keiko
    Cho, Yuko
    Takita, Junko
    Goto, Hiroaki
    Sakamaki, Hisashi
    Yabe, Hiromasa
    Kawa, Keisei
    Suzuki, Ritsuro
    Kudo, Kazuko
    Kato, Koji
    BLOOD, 2013, 122 (21)
  • [27] Feasibility of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens for refractory myeloid malignancies.
    Hamaki, T
    Kami, M
    Kim, SW
    Yamamoto, R
    Imataki, O
    Suyama, H
    Arima, F
    Nakai, K
    Saito, T
    Kanda, Y
    Makimoto, A
    Tanosaki, R
    Mineishi, S
    Takaue, Y
    BLOOD, 2002, 100 (11) : 851A - 851A
  • [28] COMPARISON OF FLUDARABINE-MELPHALAN AND FLUDARABINE-TREOSULFAN AS CONDITIONING REGIMENS PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Liga, Maria
    Tsokanas, Dimitris
    Sagiadinou, Eleftheria
    Lysandrou, Memnon
    Georgopoulou, Angeliki
    Triantafyllou, Evangelia
    Zacharioudaki, Vassiliki
    Christopoulou, Anastasia
    Spyridonidis, Alexandros
    BONE MARROW TRANSPLANTATION, 2024, 59 : 273 - 274
  • [29] FAVORABLE OUTCOMES OF REDUCED-INTENSITY CONDITIONING REGIMENS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH ACUTE LEUKEMIA
    Koh, K.
    Seo, J.
    Choi, E.
    Im, H.
    Seo, J.
    HAEMATOLOGICA, 2013, 98 : 663 - 663
  • [30] Treosulfan, Fludarabine and Cytarabine As Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation
    Hilgendorf, Inken
    Winkelmann, Nils
    Frietsch, Jochen J.
    Hunstig, Friederike
    Schnetzke, Ulf
    Scholl, Sebastian
    Hochhaus, Andreas
    Casper, Jochen
    BLOOD, 2018, 132
12345